Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. S. Boye
Improved Treatment Satisfaction and Weight-Related Quality of Life With Exenatide Once Weekly or Twice Daily
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Exenatide Extended-Release: A Once Weekly Treatment for Patients With Type 2 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Comparisons Between Twice-Daily and Once-Daily Training Sessions in Male Weight Lifters
International Journal of Sports Physiology and Performance
Sports Medicine
Physical Therapy
Sports Science
Orthopedics
Sports Therapy
Rehabilitation
Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma
Respiratory Research
Pulmonary
Respiratory Medicine
DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Adherence to Liraglutide Once Daily or Exenatide Once Weekly Over a 12-Month Period Among Commercially Insured Patients With Type 2 Diabetes Mellitus: A Retrospective Observational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Evidence for Twice-Daily Nasal Steroids Versus Once Daily for Treatment of Chronic Rhinosinusitis With Nasal Polyps
Journal of Allergy and Clinical Immunology
Allergy
Immunology
The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
Exenatide Once-Weekly Injection for the Treatment of Type 2 Diabetes in Chinese Patients: Current Perspectives
Therapeutics and Clinical Risk Management
